Tarena Jo Sisk, APRN, CNM | |
7900 Henneman Way Ste 100, Mckinney, TX 75070-2906 | |
(214) 554-6600 | |
Not Available |
Full Name | Tarena Jo Sisk |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 7900 Henneman Way Ste 100, Mckinney, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922378025 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | 2500001 (Kansas) | Secondary |
367A00000X | Advanced Practice Midwife | 1074958 (Texas) | Primary |
Entity Name | Sunflower Ob-gyn Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578681631 PECOS PAC ID: 0244336519 Enrollment ID: O20070502000497 |
News Archive
In this Global Health Magazine opinion piece, Aaron Emmel, senior policy advisor at PATH, examines a momentum for reform in foreign aid that "has been mounting in both Congress and the Administration," writing, "Now we face one of the most austere budget environments in our nation's history, making the need for an efficient, accountable, transparent, effective, and strategic foreign assistance policy all the more important. Clearly, foreign aid needs to be reformed so that it can do the job it was originally intended for: assisting the people who need it most in the most efficient and effective way possible."
New research, from scientists at Imperial College London, unravels how so-called bacterial persister cells manipulate our immune cells, potentially opening new avenues to finding ways of clearing these bacterial cells from the body, and stopping recurrence of the bacterial infection.
Genentech, a member of the Roche Group, announced today that people with HER2-positive metastatic breast cancer (mBC) lived significantly longer (overall survival) when treated with the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy, compared to Herceptin and docetaxel chemotherapy alone in the Phase III CLEOPATRA study.
Convio, Inc. announced today that Juvenile Diabetes Research Foundation (JDRF) has selected Convio as their standard for constituent relationship management (CRM), online marketing and fundraising, and special events for JDRF's national headquarters and all chapters. JDRF will use Convio's integrated, on-demand marketing, fundraising and advocacy suite to power and support their efforts to engage constituents and raise money.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Tarena Jo Sisk, APRN, CNM 7900 Henneman Way, Mckinney, TX 75070-2914 Ph: (214) 544-6600 | Tarena Jo Sisk, APRN, CNM 7900 Henneman Way Ste 100, Mckinney, TX 75070-2906 Ph: (214) 554-6600 |
News Archive
In this Global Health Magazine opinion piece, Aaron Emmel, senior policy advisor at PATH, examines a momentum for reform in foreign aid that "has been mounting in both Congress and the Administration," writing, "Now we face one of the most austere budget environments in our nation's history, making the need for an efficient, accountable, transparent, effective, and strategic foreign assistance policy all the more important. Clearly, foreign aid needs to be reformed so that it can do the job it was originally intended for: assisting the people who need it most in the most efficient and effective way possible."
New research, from scientists at Imperial College London, unravels how so-called bacterial persister cells manipulate our immune cells, potentially opening new avenues to finding ways of clearing these bacterial cells from the body, and stopping recurrence of the bacterial infection.
Genentech, a member of the Roche Group, announced today that people with HER2-positive metastatic breast cancer (mBC) lived significantly longer (overall survival) when treated with the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy, compared to Herceptin and docetaxel chemotherapy alone in the Phase III CLEOPATRA study.
Convio, Inc. announced today that Juvenile Diabetes Research Foundation (JDRF) has selected Convio as their standard for constituent relationship management (CRM), online marketing and fundraising, and special events for JDRF's national headquarters and all chapters. JDRF will use Convio's integrated, on-demand marketing, fundraising and advocacy suite to power and support their efforts to engage constituents and raise money.
› Verified 9 days ago
Kristen Parks, WHNP, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 7900 Henneman Way Ste 100, Mckinney, TX 75070 Phone: 214-544-6600 | |
Rebekah Dawn Pairsh, CNM, FNP Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 6800 State Highway 121, Mckinney, TX 75070 Phone: 469-800-5680 | |
Mary Foley Banner, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 7900 Henneman Way, Mckinney, TX 75070 Phone: 214-544-6600 Fax: 844-560-1196 | |
Mrs. Adeyinka Sokunbi, APRN CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 1400 N Coit Rd Ste 302, Mckinney, TX 75071 Phone: 214-519-9785 Fax: 214-513-3749 | |
Julie A Charlton, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4541 Medical Center Dr, Mckinney, TX 75069 Phone: 972-542-8884 Fax: 972-542-4056 | |
Ms. Breona Lashawn Black, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 6609 Virginia Pkwy, Mckinney, TX 75071 Phone: 972-542-8884 | |
Emily Portis, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 7900 Henneman Way Ste 100, Mckinney, TX 75070 Phone: 214-544-6600 Fax: 214-544-7770 |